We are thrilled to announce that Samay has successfully raised $5,200,000 in funding to further our mission to combat respiratory diseases. As a trailblazer in health technology, Samay is dedicated to empowering patients, caregivers, and clinicians with high-quality, actionable health information that can be utilized in the comfort of their homes. With the backing of esteemed organizations such as the National Science Foundation (NSF) and the National Institutes of Health (NIH), our innovative approach leverages patented “acoustic resonance” technology to revolutionize the way respiratory conditions are diagnosed and monitored. This cutting-edge technology enables us to detect air trapping, a critical yet often overlooked early marker of lung dysfunction, allowing for proactive management before patients experience significant deterioration. What sets our solution apart is its affordability; we are proud to offer a method that utilizes low-cost, over-the-counter sensors that are approximately 100 times cheaper than traditional diagnostic tools. This funding round will facilitate further research, development, and deployment of our technology, enhancing our ability to deliver precise diagnostics and empower patients with the tools they need to manage their respiratory health effectively. We are excited to take this next step in our journey and invite stakeholders to join us in our fight against respiratory diseases, striving for a future where every individual is equipped with the resources they need for optimal lung health. Together, we can make a lasting impact on the lives of millions.








